Navigation Links
Potential new therapeutic molecular target to fight cancer
Date:11/1/2007

Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.

In the Nov. 1 issue of the journal Cancer Research, researchers examined human colon and breast cancer cells and established a role of sphingosine kinase 2 (SphK2), an enzyme that forms the potent lipid mediator sphingosine-1-phosphate in the death of cancer cells mediated by the chemotherapeutic drug, doxorubicin.

Doxorubicin is able to kill cancer cells by working with p53, one of the most protective anti-cancer proteins in the human body. However, doxorubicin also relies on p53- independent mechanisms to induce death in colon and breast cancer cells.

Understanding how doxorubicin kills in a p53-independent manner is a major goal of cancer researchers because most cancer cells have mutated p53, said lead author Sarah Spiegel, Ph.D., chair and professor in the VCU Department of Biochemistry and Molecular Biology and co-leader of the cancer center's cancer cell biology program.

According to Spiegel, the study demonstrated that SphK2 is important for p53-independent induction of expression of p21, a cyclin-dependent kinase inhibitor. This p21 regulates the cell cycle, and apoptosis or programmed cell suicide, mediated by doxorubicin. Human colon and breast cancer cells were killed more efficiently by doxorubicin when SphK2 was removed from the cells.

Therefore, the findings suggest that SphK2 influences the balance between cytostasis, and apoptosis of human cancer cells, Spiegel said. Cytostasis refers to the stoppage of cellular growth and multiplication.

Spiegel said that cell death was induced by doxorubicin and decreased p21.

Spiegel, who is internationally recognized for her pioneering work on new lipid mediators that regulate cell growth and cell death, and her colleague
'/>"/>

Contact: Sathya Achia-Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Novel Enzyme Shows Potential As An Anti-HIV Target
2. Potential Cure for Lymphoma in HIV patients
3. MetaChip provides quick, efficient toxicity screening of potential drugs
4. Simple drug has the potential to save many lives threatened by malaria
5. Potential treatments for neurofibromatosis
6. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
7. Potential Drug Target For Treating Cocaine Abuse Found
8. Scripps scientists find potential for catastrophic shifts in Pacific ecosystems
9. Engineers improve plastics potential for use in implants by linking it to biological material
10. Human embryonic stem cells have the potential to develop into eggs and sperm in the laboratory
11. Improving the potential of cancer vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... nominated for the 2015 New York Design Awards under ... Design100, New York City Design Awards are part of ... on over 2,500 ratings from the marketplace, industry and ...
(Date:4/13/2015)... -- higi, a leading cloud-based consumer engagement platform that provides ... their communities around health and wellness, announced today the ... ... convenient vehicle to receive validated health information from consumers. ... API will allow higi,s trusted partners, on a user ...
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
... September 2009) -- IEEE-USA President Gordon Day said today ... released by the White House and discussed by President ... Community College in Troy, N.Y. "IEEE-USA recognizes the ... plays in ensuring U.S. competitiveness, energy independence and national ...
... of Standards and Technology (NIST), in collaboration with ... a new reference material for beryllium. Beryllium, an ... high-performance alloys and ceramics, can cause berylliosisa chronic, ... material is expected to dramatically improve methods used ...
... The standard explanation for what causes Alzheimer,s is known as ... of an accumulation of the peptide amyloid beta, the toxic ... sticky plaques that have defined Alzheimer,s for more than 100 ... yearly targeting this toxic peptide but what if this ...
Cached Biology News:New beryllium reference material for occupational safety monitoring 2Rethinking Alzheimer's disease and its treatment targets 2Rethinking Alzheimer's disease and its treatment targets 3
(Date:4/23/2015)... 23, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... first quarter 2015 results before the Nasdaq market opens ... a live conference call and webcast to discuss its financial ... 30, 2015 at 8:00 a.m. Eastern Time (5:00 a.m. ... conference call by dialing 866-952-1906 (US) or 785-424-1825 (International) ...
(Date:4/23/2015)... , April 23, 2015  Cryoport, Inc. (OTCBB: ... logistics solutions for the life sciences industry, today ... cryogenic logistics solutions within the animal husbandry market ... Farms to support the shipment of equine semen ... horse Stallions. Animal husbandry is ...
(Date:4/23/2015)... Bethlehem, PA (PRWEB) April 23, 2015 ... announce it is the first EMC® Enterprise Content ... on the entire EMC Documentum® for Life ... Glemser has proven knowledge and capabilities to provide ... Documentum-based, purpose-built solutions. , The EMC Documentum ...
(Date:4/23/2015)... NEW YORK , April 23, 2015 /PRNewswire/ ... development stage healthcare company, focuses on the development ... colorectal cancer. The company lead product includes PRP, ... as trypsinogen and chymotrypsinogen, as well as the ... It is also developing a combination of anti-cancer ...
Breaking Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 3Glemser Earns Accreditation for Life Sciences Solution Suite 2Early Stage BioTech offers Plenty of Risk; Propanc Health Group Analyst Brief Issued by BrokerBank Securities, Inc. 2
... , ATLANTA, Sept. 14 CryoLife, Inc. ... medical device and cardiovascular tissue processing company, announced today that it ... Conference at the Grand Hyatt New York in New York City. ... executive officer of CryoLife, Inc., will present Monday, September 21 at ...
... , NATICK, Mass., Sept. ... ) today announced that it has entered into a ... company offering advanced testing solutions for urinary incontinence. ... combines staffing, equipment, supplies and results analysis, helping to ...
... , HOLDEN, Mass., Sept. ... appointment of Elkan Gamzu, Ph.D. as Chairman to its ... years of pharmaceutical and biotechnology experience and has held ... President of Project Management at Millenium Pharmaceuticals, CEO of ...
Cached Biology Technology:CryoLife to Present at UBS Global Life Sciences Conference 2Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network 2Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network 3Elkan Gamzu, Ph.D. Joins Hygeia Therapeutics' Board of Directors as Chair 2
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... Laminin-Based 96-well Cell Invasion Assay is designed ... using laminin as a significant barrier to ... in vitro in a convenient, high-throughput, 96-well ... appropriate for all types of adherent cells ...
... The GrabIt™ Kits are designed for the ... using a pull-down method. Proteins that interact ... fusion proteins are copurified using affinity ... are retained on a spin filter. The ...
Kit containing MACS equipment and reagents for immunopurification of proteins....
Biology Products: